Dana Antakly is an associate in the firm’s Business Law Department and a member of its Technology Companies and Life Sciences Groups. Ms. Antakly represents public and private companies as well as venture capital funds and investment banks across the technology industry, including clients in the software, hardware, biotechnology, pharmaceuticals and other technology-driven industries. Her practice includes public and private securities offerings, mergers and acquisitions, and other complex transactions, as well as general corporate matters. She joined Goodwin in 2013.




Ms. Antakly’s transactional experience includes representing:

  • bluebird bio in several public offerings totaling more than $1 billion
  • HubSpot in its $144 million initial public offering and $167 follow-on offering
  • Mimecast in its $77.5 million initial public offering and $62 million follow-on offering
  • AMAG Pharmaceuticals in its $300 million convertible notes offering
  • the underwriters in the $287 million initial public offering of trivago
  • the underwriters in the $240 million initial public offering of SailPoint Technologies
  • the underwriters in the $100 million initial public offering of Acacia Communications and $450 million follow-on offering
  • the underwriters in the $100 million initial public offering of InflaRx
  • the underwriters in a $144 million offering of Carbonite
  • Novacap Industries in its acquisition of Dialogic
  • Ocata Therapeutics in its sale to Astellas Pharma
  • AppNexus in several strategic acquisitions 
  • Bit9 in its acquisition of Carbon Black
Professional Activities

Ms. Antakly is a member of the Boston Bar Association. While in law school, Ms. Antakly served as an Executive Editor for the Ottawa Law Review.

In The News







J.D., 2013
University of Ottawa

(magna cum laude)

B.S., 2010
McGill University
(with distinction)



Get In Touch
Get In Touch
Our clients rely on us for world-class advisory services, counsel on complex transactional work and high-stakes litigation. Specializing in matters involving the financial, life sciences, private equity, real estate, and technology industries, we use a collaborative, cross-disciplinary approach to resolve our clients’ most challenging issues. To find out more, please contact us.
Unsere Kunden verlassen sich auf uns für erstklassige Beratungsdienste, beraten über komplexe Transaktionsarbeiten und High-Stakes-Prozesse. Spezialisiert auf Angelegenheiten der Finanz-, Life-Sciences-, Private-Equity-, Immobilien-und Technologie-Industrie, verwenden wir eine kooperative, interdisziplinäre Ansatz zur Lösung unserer Kunden am schwierigsten Fragen. Um mehr zu erfahren, kontaktieren Sie uns bitte.


Search Other Lawyers